Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
recognizes that pediatricians and pediatric endocrinologists have special needs and
requirements for the laboratory testing of their patients. Age-specific reference intervals and
specimen collection issues are particular concerns in pediatric patient care and evaluation.
Frequently, adult reference intervals are not appropriate for pediatric patients. To assist physicians in treating their pediatric patients, this document lists age-specific reference intervals for
many of the endocrine tests offered by LabCorp. Where available, reference ranges are also
provided by Tanner stage.
LabCorp realizes that pediatric specimen collection can be challenging and is a major concern
for health care providers. It is frequently difficult to obtain substantial volumes of blood or
urine from pediatric patients. For this reason, we have provided an appropriate specimen
volume as well as an analytical minimum specimen volume for each test. The minimum volumes listed in this document represent the analytical minimum specimen required to perform
the test once. This volume does not permit any repeat analysis. It is highly recommended that
the preferred volume indicated below be submitted whenever possible.
Age
Male/Female
Age
Male
Female
< 1 yr
1-3 yr
4-7 yr
8-11 yr
12-16 yr
5.0-132.0
5.0-60.0
4.0-76.0
3.0-28.0
1.0-18.0
0-3 yr
4-5 yr
6-7 yr
8-9 yr
10-11 yr
12-13 yr
14-15 yr
16-20 yr
Tanner Stage
I (< 8yr)
I (> 8yr)
II
III
IV
V
< 80
< 70
< 399
< 220
< 311
< 737
131-1395
103-2603
< 60
< 155
< 330
< 140
< 340
78-441
73-760
113-732
<400
<513
<707
94-568
284-1205
103-2630
< 330
< 144
66-174
96-441
79-854
73-732
Age
Male/Female
0-1 mo
2-11 mo
1-15 yr
1-11
1-22
2 -16
Note: Use plastic transport tubes for all frozen specimens. In addition, to avoid delays in turnaround time when requesting multiple tests on frozen samples, please
submit separate specimens for each test requested.
Age
Male
Female
0-5 mo
6-11 mo
1-5 yr
6-9 yr
10-11 yr
12-14 yr
15-17 yr
Tanner Stage
I (<7 yr)
I (>7 yr)
II
III
IV
5-45
5-30
5-45
5-55
10-30
20-85
35-100
5-35
5-25
5-40
5-45
25-80
15-175
55-200
< 35
< 49
< 89
11-91
<219
< 42
< 83
<143
<152
28-252
Age
Male/Female
0-2 yr
3-7 yr
8-14 yr
>14 yr
5-83
8-76
6-89
8-52
Age
Range
0-1 mo
2-11 mo
1-18 yr
Age
Male
Female
0-1 mo
1-6 mo
7-11 mo
1-3 yr
4-6 yr
7-9 yr
10-12 yr
13-15 yr
16-18 yr
1.6-4.8
1.4-3.3
0.9-3.1
0.8-2.2
0.6-2.3
0.8-1.7
0.7-1.8
0.7-2.0
0.7-1.9
1.7-4.5
1.0-3.8
1.0-2.3
0.7-2.4
0.5-2.2
0.7-1.8
0.7-2.0
0.8-1.9
0.6-1.9
Age
Male
Female
< 1 yr
1-2 yr
3-4 yr
5-6 yr
7-8 yr
9-10 yr
11-12 yr
13-14 yr
15-16 yr
47-157
26-99
27-101
34-116
34-108
39-139
20-166
11-195
23-170
57-109
26-129
31-95
33-105
21-133
29-157
42-154
< 113
< 69
Epinephrine
Male/Female
Age
2-9 days
10 days-2 mo
3 mo-11 mo
12-23 mo
24-35 mo
3-15 yr
Age
36-401
55-201
55-438
36-639
18-438
18-456
Norepinephrine
Male/Female
2-9 days
10 days-2 mo
3 mo-11 mo
12-23 mo
24-35 mo
3-15 yr
169-1184
372-2081
271-1117
68-1810
186-1472
85-1252
Age
0-23 mo
2-4 yr
5-9 yr
10-19 yr
Epinephrine
Male/Female
< 75
< 57
< 35
< 34
Note: Use plastic transport tubes for all frozen specimens. In addition, to avoid delays in turnaround time when requesting multiple tests on frozen samples, please
submit separate specimens for each test requested.
Age
Norepinephrine
Male/Female
0-23 mo
2-4 yr
5-9 yr
10-19 yr
< 420
< 120
< 89
< 82
Dopamine
Age
Male/Female
0-23 mo
2-4 yr
5-9 yr
10-19 yr
< 3000
< 1533
< 1048
< 545
Age
Male
Female
5th day
2 mo-13 yr
14-15 yr
16-18 yr
Tanner Stage
II-III
IV-V
0.6-19.8
2.4-22.9
2.5-22.9
2.4-28.6
0.6-19.8
2.4-22.9
2.5-28.6
2.4-28.6
2.7-13.4
3.7-15.3
1.4-16.2
4.5-15.7
Age
Male/Female
2-11 yr
12-16 yr
1-21
2-38
Age
Male/Female
0-9 yr
10-16 yr
0.0-3.3
0.4-3.3
Age
Male
Female
0-5 yr
6-7 yr
8-9 yr
10-11 yr
12-14 yr
Tanner Stage
I
II
III
IV
V
26-72
29-66
53-135
183-383
240-520
19-42
73-165
74-180
234-529
224-611
31-345
110-495
170-585
160-640
250-900
31-345
150-570
200-600
200-780
215-850
Age
Male
Female
1-7 days
8-15 days
1-3 yr
4-6 yr
7-8 yr
9-10 yr
11 yr
12 yr
13 yr
14 yr
15 yr
16 yr
17 yr
18-19 yr
Tanner Stage
I
II & III
IV
V
91-376
37-224
< 30
< 186
< 94
< 75
< 152
< 344
< 242
< 286
59-310
47-357
102-341
108-441
73-367
44-247
< 79
< 38
< 68
< 160
< 98
< 177
< 167
32-301
39-288
58-354
97-399
145-395
< 87
< 151
75-282
121-368
< 65
< 175
57-230
76-378
Note: Use plastic transport tubes for all frozen specimens. In addition, to avoid delays in turnaround time when requesting multiple tests on frozen samples, please
submit separate specimens for each test requested.
Age
Male
Female
8-11 yr
12-18 yr
7.6-20.8
1.4-24.2
7.7-22.1
0.0-20.6
Age
Male
Female
Newborn
Prepubertal
Tanner Stage
I
II
III
IV
V
Adult
5.0-60.0
<3.0
<15.0
<3.0
<3.0
3.0-17.0
8.0-33.0
22.0-52.0
24.0-65.0
30.0-85.0
<3.0
5.0-12.0
7.0-19.0
4.0-13.0
3.0-18.0
4.0-22.0
Age
Male
Female
1-3 yr
4-6 yr
7-9 yr
10-12 yr
13-15 yr
1.7-17.9
3.5-21.9
1.0-13.5
1.0-14.0
2.2-14.4
2.1-15.9
2.9-8.5
2.1-8.2
1.1-9.1
3.8-20.5
Age
Male
Female
1-6 yr
7-10 yr
11-12 yr
13-15 yr
16-17 yr
Tanner Stage
I
II
III
IV
V
<15
<15
<40
<45
10-50
<15
<70
10-300
10-300
10-300
3-15
3-10
5-15
3-40
15-45
5-10
5-115
5-180
25-345
25-410
Age
Male
Female
0-10 yr
Tanner Stage
I
II
III
IV
V
0-25
0-25
10-38
17-45
22-55
27-80
25-80
10-46
22-63
24-110
40-180
60-280
Age
Male
Female
0-5 yr
6-7 yr
8-9 yr
10-11 yr
12-14 yr
Tanner Stage
I
II
III
IV
V
18-53
17-48
20-54
21-49
17-44
19-46
17-44
31-70
28-68
57-140
5-17
10-25
15-25
15-45
20-45
4-29
10-33
15-43
16-77
29-105
Age
Male
Female
0-23 mo
2-5 yr
6-10 yr
11-20 yr
Tanner Stage
I & II
III & IV
V
0.4-2.1
0.4-1.7
0.4-1.6
0.4-8.7
0.4-7.1
0.4-4.2
0.4-3.0
0.4-8.6
0.3-4.6
1.2-15.4
1.5-6.8
0.7-6.7
1.0-7.4
1.0-9.2
*This test may be considered by Medicare and other carriers as investigational and, therefore, may not be payable by the carrier as a covered benefit for patients.
Note: Use plastic transport tubes for all frozen specimens. In addition, to avoid delays in turnaround time when requesting multiple tests on frozen samples, please
submit separate specimens for each test requested.
Age
Male/Female
Age
Male
Female
69-190
55-186
2-168
3-117
1-125
< 1 yr
1-5 yr
6-12 yr
Tanner Stage
II-III
IV-V
14-77
12-103
31-186
62-287
10-47
11-141
20-363
32-297
58-450
53-542
0-1 mo
2-22 mo
22 mo-16 yr (fasting 3-4 hr)
22 mo-16 yr (fasting 5-6 hr)
22 mo-16 yr (fasting >8 hr)
Age
Male/Female
1 day
1 wk
1-12 mo
1 yr to Adult
5-53
5-27
2-10
Less than 5.0
Age
Male
Female
< 1mo
1-5 mo
6-11 mo
1-3 yr
4-6 yr
7-9 yr
10-12 yr
13-15 yr
16-18 yr
53-186
35-157
6-40
2-19
1-34
1-45
1-34
23-82
8-100
17-204
25-110
5-47
3-51
4-34
4-44
3-33
2-72
3-91
Age
Male/Female
0-2 mo
3-11 mo
12-23 mo
2-4 yr
5-9 yr
10-15 yr
11.3-35.0
8.4-44.9
12.2-31.8
3.4-32.0
6.8-23.7
3.2-13.6
Tanner Stage
Male/Female
I
II & III
IV & V
2.6-15.5
8.3-22.0
8.5-23.0
Age
Male/Female
3-8 yr
9-12 yr
13-17 yr
1.2-16.2
2.4-8.7
1.8-5.5
*This test may be considered by Medicare and other carriers as investigational and, therefore, may not be payable by the carrier as a covered benefit for patients.
Note: Use plastic transport tubes for all frozen specimens. In addition, to avoid delays in turnaround time when requesting multiple tests on frozen samples, please
submit separate specimens for each test requested.
Age
Male
Female
2 mo-5 yr
6-8 yr
9-11 yr
12-15 yr
16-24 yr
Tanner Stage
I
II
III
IV
V
17-248
88-474
110-565
202-957
182-780
17-248
88-474
117-771
261-1096
182-780
Age
Male/Female
0-11 mo
1-10 yr
11-14 yr
<1.0
<5.0
<12.0
109-485
174-512
230-818
396-776
402-839
128-470
186-695
292-883
394-920
308-1138
Age
Male
Female
0-4 yr
5-9 yr
10-11 yr
12-13 yr
14-16 yr
<2
<3
1-5
1-6
3-13
<2
<3
1-5
1-6
2-8
Age
Male/Female
Newborn
0-2 yr
3-4 yr
5-6 yr
7-8 yr
9-10 yr
11-12 yr
13-14 yr
15-18 yr
78 - 574
206 - 674
211 - 727
281 - 1041
380 - 1140
455 - 1207
386 - 1122
342 - 1102
398 - 1230
Age
Male
Female
0-1 yr
2-3 yr
4-5 yr
6-7 yr
8-9 yr
10-11 yr
12-13 yr
14-15 yr
16-17 yr
18-20 yr
0.9 - 1.8
1.1 - 2.3
1.2 - 3.1
1.3 - 3.4
1.4 - 3.9
1.5 - 5.0
1.7 - 5.1
1.9 - 6.4
1.7 - 6.0
1.5 - 6.0
0.7 - 2.5
0.8 - 3.8
1.3 - 3.6
1.2 - 4.7
1.6 - 4.0
1.9 - 5.5
1.8 - 6.1
2.0 - 5.4
1.9 - 5.3
1.6 - 6.0
Age
Male
Female
0-23 mo
2-10 yr
11-20 yr
Tanner Stage
I
II
III
IV & V
0.5-1.9
0.0-0.5
0.5-5.3
0.0-0.5
0.0-0.5
0.5-9.0
0.0-3.6
0.3-4.8
0.6-6.3
0.6-7.8
0.0-3.0
0.1-4.1
0.2-9.1
0.5-15.0
Age
Metanephrine
Normetanephrine
3-8 yr
9-12 yr
13-17 yr
5-113
21-154
32-167
13-252
32-346
63-402
Age
Male/Female
0-18 yr
0.9-3.4
*This test may be considered by Medicare and other carriers as investigational and, therefore, may not be payable by the carrier as a covered benefit for patients.
Note: Use plastic transport tubes for all frozen specimens. In addition, to avoid delays in turnaround time when requesting multiple tests on frozen samples, please
submit separate specimens for each test requested.
Tanner Stage
Male
Female
I
II
III
IV
V
55-508
21-423
27-462
<609
<240
6-662
193-514
13-632
<389
<132
Age
Male
Female
6 yr
7 yr
8 yr
9 yr
10 yr
11 yr
12 yr
13 yr
14 yr
15 yr
16 yr
17 yr
18 yr
19 yr
< 28
< 41
< 54
< 48
< 47
< 76
< 126
< 99
< 116
< 115
< 70
< 41
< 38
< 28
< 52
< 53
< 54
< 46
< 61
< 83
< 94
< 96
< 75
< 32
< 32
< 26
< 17
< 16
Age
Male/Female
2-20 yr
9-52
Age
Male
Female
< 1 yr
1-5 yr
6-12 yr
Tanner Stage
II & III
IV-V
10-137
10-43
15-45
18-87
19-48
17-38
15-84
20-77
10-45
11-50
Age
Male
Female
1-10 yr
Tanner Stage
I
II
III
IV
V
< 0.5
< 0.5
< 0.3
< 0.3
< 0.5
< 1.1
0.2-0.8
< 0.3
< 0.5
< 4.5
< 13.0
0.2-9.5
Age
Male
Female
<1 mo
1-11 mo
1-3 yr
4-6 yr
7-9 yr
10-12 yr
13-15 yr
3.7-81.2
0.3-28.9
2.3-13.2
0.8-16.9
1.9-11.6
0.9-12.9
1.6-16.6
0.3-95.0
0.2-29.9
1.0-17.0
1.6-13.1
0.3-12.9
1.9-9.6
3.0-14.4
Age
Range
1-6 yr
7-12 yr
13-17 yr
4-89
3-66
2-37
Age
Male/Female
0-1 mo
2-11 mo
1-3 yr
4-5 yr
6-10 yr
11-15 yr
2.0-35.0
2.4-37.0
1.7-11.2
1.0-6.5
0.5-5.9
0.5-3.3
Age
Male/Female
0-18 yr
113-431
Note: Use plastic transport tubes for all frozen specimens. In addition, to avoid delays in turnaround time when requesting multiple tests on frozen samples, please
submit separate specimens for each test requested.
Age
Male/Female
0-19 mo
20 mo - 15 yr
164-424
537-903
Age
Male
Female
0-1 mo
1-12 mo
1-3 yr
4-6 yr
7-9 yr
10-12 yr
13-15 yr
16-18 yr
11-71
60-209
42-156
39-146
38-114
32-93
13-93
11-54
12-51
50-181
51-158
48-142
31-103
20-100
17 -77
9-75
Age
Male
Female
1-5 mo
6-11 mo
1-5 yr
6-7 yr
8-10 yr
11-12 yr
13-15 yr
Tanner Stage
I
II
III
IV
V
1-177
2-7
0-10
0-20
0-25
0-350
15-500
1-5
2-5
0-10
0-10
0-30
0-50
0-50
2-23
5-70
15-280
105-545
265-800
2-10
5-30
10-30
15-40
10-40
Age
Cord Blood
1-15 days
1-2 mo
3-5 mo
6-7 mo
6-9 yr
10-11 yr
12-14 yr
15-17 yr
0.50-2.20
0.15-3.10
0.33-0.80
0.07-1.40
0.04-0.48
0.01-0.32
0.06-0.57
0.14-15.60
8.00-15.90
0.40-1.60
0.05-0.25
0.01-0.13
0.03-0.11
0.02-0.06
0.01-0.09
0.10-0.52
0.10-0.52
0.10-0.52
2.0-4.4
0.9-1.7
0.4-0.8
0.4-1.1
0.4-1.0
0.9-1.7
1.0-1.9
1.3-3.0
1.8-2.7
2.0-3.9
0.8-1.5
0.4-1.1
0.5-1.0
0.5-0.8
0.9-1.4
1.0-1.9
1.0-1.9
1.0-1.9
Term Infants
Male/Female
Cord Blood
1 day
10 day
5-65
6-93
9-148
107-395
49-163
17-63
*This test may be considered by Medicare and other carriers as investigational and, therefore, may not be payable by the carrier as a covered benefit for patients.
Note: Use plastic transport tubes for all frozen specimens. In addition, to avoid delays in turnaround time when requesting multiple tests on frozen samples, please
submit separate specimens for each test requested.
147-277
32-112
19-51
20-50
9-27
Age
Male
Female
1-11 mo
1-3 yr
4-6 yr
7-12 yr
13-18 yr
16-33
16-32
17-30
17-29
13-26
18-32
19-34
18-31
15-29
14-29
Age
Male
Female
1-30 days
1 mo-5 yr
6-18 yr
0.52-16.00
0.55-7.10
0.37-6.00
0.72-13.10
0.46-8.10
0.36-5.80
Age
Male
Female
< 1 mo
1-11 mo
1-3 yr
4-6 yr
7-12 yr
13-15 yr
5.9-21.5
6.4-13.9
7.0-13.1
6.1-12.6
6.7-13.4
4.8-11.5
6.3-21.5
4.9-13.7
7.1-14.1
7.2-14.0
6.1-12.1
5.8-11.2
Age
Range
Birth-4 days
2 wk - 20 yr
2.2-5.3
0.8-2.0
Age
Male
Female
1-3 days
4-30 days
1-11 mo
1-5 yr
6-10 yr
11-15 yr
16-18 yr
0.80-2.78
0.48-2.32
0.76-2.00
0.90-1.59
0.81-1.68
0.92-1.57
0.92-1.53
0.88-1.93
0.61-1.93
0.88-1.84
1.02-1.72
0.82-1.58
0.79-1.49
0.83-1.44
Age
Male
Female
0-1 mo
2-11 mo
1-5 yr
6-10 yr
11-15 yr
16-18 yr
15-210
95-275
80-253
96-232
73-199
69-201
15-200
50-264
126-258
104-227
96-211
91-164
Age
Male
Female
1-3 days
4-30 days
1-11 mo
1-5 yr
6-10 yr
11-15 yr
16-18 yr
1.4-4.8
1.4-5.5
2.0-6.9
2.4-6.7
2.9-6.0
3.1-5.9
3.5-5.7
1.4-5.4
1.5-5.0
2.5-6.5
3.0-6.0
2.7-6.2
2.6-5.7
2.8-5.2
Age
Male/Female
1-4 yr
5-9 yr
10-15 yr
150-710
170-790
190-880
Note: Use plastic transport tubes for all frozen specimens. In addition, to avoid delays in turnaround time when requesting multiple tests on frozen samples, please
submit separate specimens for each test requested.
Age
Male
Female
0-11 mo
1-3 yr
4-6 yr
7-12 yr
11-15 yr
16-18 yr
23-34
24-35
24-34
24-33
25-37
24-38
23-36
24-36
24-35
22-35
23-37
23-35
Age
Male/Female
0-1 yr
2-4 yr
5-9 yr
10-19 yr
0-18.8
0-11.0
0-8.3
0-8.2
Age
< 1 mo
1-11 mo
1-3 yr
4-12 yr
13-18 yr
Age
< 1 mo
1-11 mo
1-3 yr
4-12 yr
13-18 yr
Summer Ranges
Male
11-44
26-48
12-60
9-49
9-41
Winter Ranges
Male
8-38
13-68
16-51
11-47
6-39
Female
11-41
23-62
18-62
7-48
7-38
Female
6-42
18-48
17-53
14-40
6-28
Note: Use plastic transport tubes for all frozen specimens. In addition, to avoid delays in turnaround time when requesting multiple tests on frozen samples,
please submit separate specimens for each test requested.
10
References
Aldosterone, Serum
Meites S, Buffone GJ, Cheng MH, et al, eds. Pediatric Clinical Chemistry, Reference (Normal) Values. 3rd ed. Washington, DC: AACC Press;
1989:45.
Stark P, Beckerhoff R, Leumann EP, et al. Control of plasma aldosterone in infancy and childhood. Helv Paediatr Acta. 1976; 30:349-356.
Aldosterone, Urine
Meites S, Buffone GJ, Cheng MH, et al, eds. Pediatric Clinical Chemistry, Reference (Normal) Values. 3rd ed. Washington, DC: AACC Press;
1989:45-46.
Loeuile GA, Racadot A, Vasseur P, Vandewalle B. Blood and urinary aldosterone levels in normal neonates, infants and children. Pediatrie.
1981; 36:335-344.
,17-Diol Glucuronide
5
-Androstane-3
Rittner HL, Lee PDK, Blum WF, et al. Developmental patterns of serum 3 alpha-androstanediol glucuronide. J Edocrinol Invest. 1997;
20:245-250.
Androstenedione
Soldin SJ, Hicks JM, eds. Pediatric Reference Ranges. Washington, DC: AACC Press; 1995: 30.
Meites S, Buffone GJ, Cheng MH, et al, eds. Pediatric Clinical Chemistry, Reference (Normal) Values. 3rd ed. Washington, DC: AACC Press;
1989:56.
Angiotensin-converting Enzyme
Tietz NW, ed. Clinical Guide to Laboratory Tests. 3rd ed. Philadelphia: W.B. Saunders Company; 1995:54.
Lieberman J. Elevation of serum angiotensin-converting enzyme (ACE) level in sarcoidosis. Am J Med. 1975; 59:365.
Antidiuretic Hormone
Rascher W, Rauh W, Brandeis WE, Huber K-H, Schrer K. Determinants of plasma arginine-vasopressin in children. Acta Paediatr Scand.
1986;75:111-117.
2-Microglobulin
Soldin SJ, Hicks JM, Bailey J, Beatey J, Watson P. Pediatric reference ranges for B2-microglobulin and ceruloplasmin. Clin Chem. 1997;
43:S199.
Bone-Specific Alkaline Phoshphatase
Tobiume H, Kanzaki S, Hida S, et al. Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth
hormone (GH) deficiency: A potential marker for bone formation and response to GH therapy. J Clin Endocrinol Metab.
1997;82(7):2056-2061.
Cathecholamines, Serum
Candito M, Albertini M, Politano S, et al. Plasma catecholamine levels in children. J Chromatogr B Biomed Sci Appl. 1993; 617:304-307.
Cathecholamines, Urine
Soldin SJ, Lam G, Pollard A, et al. High performance liquid chromatographic analysis of urinary catecholamines employing amperometric
detection: Reference values and use in laboratory diagnosis of neural crest tumors. Clin Biochem. 1980; 13:285-291.
Cortisol, Serum
Jonetz-Mentzel L, Wiedmann G. Establishment of reference ranges for cortisol in neonates, infants, children and adolescents. Eur J Clin Chem
Biochem. 1993; 31:525-529.
Lashansky G, Saenger P, Fishman K, et al. Normative data for adrenal steroidogenesis in a healthy pediatric population: Age- and sex-related
changes after adrenocorticotropin stimulation. J Clin Endocrinol Metab. 1991; 73:674-686.
Cortisol, Urine
Tietz NW, ed. Clinical Guide to Laboratory Tests. 3rd ed. Philadelphia: W.B. Saunders Company; 1995:174.
C-Peptide, Serum
Ratzmann KP, Strese J Kohnert DK, et al. Age-dependent relationship of fasting C-peptide concentration and insulin secretion in non-obese
subjects with normal glucose tolerance. Exp Clin Endocrinol. 1986; 88:57-63.
Dehydroepiandrosterone (DHEA)
Ducharme JR, Forest MG, De Peretti E, et al. Plasma adrenal and gonadal sex steroids in human pubertal development. J Clin Endicrinol
Metab. 1976; 42:468-476.
Tietz NW, ed. Clinical Guide to Laboratory Tests. 3rd ed. Philadelphia: W.B. Saunders Company; 1995:195-196.
11
12
13
14